16:58 EDT Merck’s hypertension drug Sotatercept gains FDA approval, Bloomberg says
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Summit Therapeutics initiated with a Buy at Stifel
- Merck: Phase 3 KEYLYNK-006 trial did not meet dual primary endpoints
- Merck: V116 vaccine for pneumococcal diseases show adult immune response
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Merck call volume above normal and directionally bullish
